Abstract
The helicase eIF4A is part of the cellular eIF4F translation initiation complex. The main functions of eIF4A are to remove secondary complex structures within the 5′-untranslated region and to displace proteins attached to mRNA. As intracellular parasites, viruses regulate the processes involved in protein synthesis, and different mechanisms related to controlling translation factors, such as eIF4A, have been found. The inhibitors of this factor are currently known; these substances could be used in the near future as part of antiviral pharmacological therapies in instances of replication cycles in which eIF4A is required. In this review, the particularities of how some viruses make use of this initiation factor to synthesize their proteins are discussed.
Similar content being viewed by others
Introduction
Viruses require viral proteins to form new particles. This process depends on the cellular translational machinery; therefore, viruses have developed mechanisms that favor the synthesis of their proteins over cellular protein synthesis [1, 2]. Different studies have suggested the possible roles of translation initiation factors during viral infections, and the eIF4F complex is one of the most widely studied translation initiation factors and is commonly used by certain viruses [3,4,5].
Consistent with the above statement, the eIF4A protein, which is part of the eIF4F complex, can be regulated during viral infection [6], but the way in which this regulation is accomplished tends to be different in each case, which means that viruses can either use it or not use it at all, or they may alternate between requiring and not requiring the protein.
The eIF4A factor and its role in translation initiation
The synthesis of proteins or translation is divided into three phases—initiation, elongation, and termination—and the objective is to translate the information contained in the mRNA [7, 8]. According to the form of initiation, the translation has been classified as cap-dependent or cap-independent [7].
The cellular mRNAs are characterized by having a structure at the 5′ end, called cap. At the 3′ end, they contain a polyadenylated tract (poly A) bound to the poly(A)-binding protein (PABP) [7, 9, 10]. In the cap-dependent mechanism, the mRNA is recruited to a protein complex called eIF4F, which is composed of three proteins: eIF4E, a cap-binding protein; eIF4A, which is a helicase; and eIF4G, which in turn joins eIF4E and eIF4A and other initiation factors like eIF3 [11,12,13]. Another complex that participates in the initiation phase is called 43S, formed by the small 40S ribosomal subunit, the eIF3 factor, and the ternary complex formed in turn by eIF2, GTP, and tRNA-methionine-initiator (Met-tRNAi). The eIF4F complex recruits the 43S complex through the interaction of eIF3 [12, 14]. The 40S ribosomal subunit carries the eIF2-GTP-Met-tRNAi complex to the start codon AUG, where the 40S and 60S ribosomal subunits bind, giving rise to the full 80S ribosome. The eIF2 protein is released together with GDP and the elongation step is started (Fig. 1) [11, 12, 15, 16].
The eIF4A factor is a DEAD-box helicase, which is composed of two recA-like domains and a flexible central hinge region [17,18,19]. This factor is part of the eIF4F complex, which is also composed of eIF4G and eIF4E [12, 13, 20]. This complex has been described as a key element in the cap-dependent translation initiation process, which is a highly regulated step [12]. One of the functions of eIF4F is to recruit mRNA for translation; however, eukaryotic mRNA presents secondary structures in the 5′-untranslated region (5′-UTR) that can make translation difficult due to their ability to prevent the assembly of the 40S ribosomal subunit, and they complicate scanning near the start codon [21]. The role of eIF4A helicase activity is to unwind 5′ UTR structures [22].
A number of studies suggest that eIF4A by itself has weak helicase activity. Such activity is stimulated when eIF4B or eIF4H initiation factors are present. In addition, eIF4A removes adhered proteins and heterogeneous ribonucleoprotein molecules from the cellular nucleus that commonly coat mRNA [21, 23, 24].
Until recently, eIF4A was considered to solely could remove structures within mRNA during protein biosynthesis, but recently, specific research has found that eIF4A can be of higher importance and that it can even function as a regulator at different levels [25, 26]. One of the events in which eIF4A participates is in the assembly of stress granules (SGs). These granules are cytoplasmic aggregates in which cellular translation is arrested under stress conditions (reviewed in [27]). Initially, SGs were suggested to be assembled as a response to the phosphorylation of the translation factor eIF2 [28]. However, more recent studies have shown that SGs are also formed as a consequence of eIF4A inactivation [26]. After the discovery that the drug Pateamine A, which favors the binding of eIF4A to mRNA in such a way that functionality is inhibited [29] and that SGs are formed as a result [26], it was proposed that eIF4A is important for protein synthesis control, and consequently, for regulation of gene expression at the translational level. Recently, different research teams have used this initiation factor as therapeutic target in cancer or during viral infections and have obtained promising and interesting results [30, 31].
In the mechanism known as cap-independent, the presence of a structure known as internal ribosome entry site (IRES) within the 5′-UTR is important for the translation of mRNA. This mechanism was initially described as a trait of the picornavirus family; however, it is now known that IRESs are not found exclusively in viral mRNAs [32, 33]. It has been observed that, in this initiation form, an mRNA with IRES can become translated without requiring any canonical initiation factor—as happens in the cricket paralysis virus (family: Dicistroviridae, genus: Cripavirus) [34]—but may have to be translated with one or more canonical factors such as eIF4A or by using cellular proteins, known as IRES trans-acting factors (ITAFs) [35,36,37], which have already been described for some viral IRESs [38].
Viral translational mechanisms that benefit from eIF4A
Some viruses employ translational mechanisms for their mRNAs that are similar to those used by cellular mRNAs. For this reason, these viruses draw on mechanisms that ensure or stabilize the formation of eIF4F. One example is cytomegalovirus, which codes for a protein known as pUL69 whose target is eIF4A (Fig. 2a). It has been demonstrated in vitro that pUL69-eIF4A binding ensures that eIF4E remains recruited within eIF4F, and thus, eIF4E is prevented from being sequestered by the regulating protein 4EBP [39]. In addition, to ensure the formation of eIF4F, cytomegalovirus stimulates the synthesis of all components of this complex [40].
The influenza virus, known for having mRNAs with characteristics similar to cellular mRNAs, uses eIF4A to synthesize its proteins. In experimental models, both in vitro and in vivo, there has been evidence of the virus needing, in addition to eIF4A, eIF4G but not eIF4E (Fig. 2b) [41].
The principal function of eIF4A is to remove complex secondary structures in mRNA regardless of the way that ribosomal units are recruited. This function of the helicase is crucial not only during cap-dependent translation as part of the eIF4F complex but also during the cap-independent translation of some viral mRNAs via IRES. Consistently, the encephalomyocarditis virus IRES has been found to use an initiation mechanism that depends on this structure in which conformational changes are required in the downstream region of the initial codon while being mediated by eIF4A (Fig. 2c) [42].
Evidence of the participation of eIF4A in the translation of other viral IRES mRNAs has established that, in some occasions, an association between eIF4A and other factors of the eIF4F complex is necessary, such as in the IRES of Kaposi’s sarcoma-associated herpesvirus [43] and calicivirus mRNAs (Fig. 2c) [44]. Although the importance of eIF4A binding to other translation factors is not fully understood, it is clear that such interactions increase translation efficiency [43, 44].
eIF4A may not be required during protein synthesis by some viruses
Each virus has evolved differently. As previously mentioned, some viruses employ the classic cap-dependent translational mechanism in which one or more canonical factors are manipulated. There is a case of viral mRNAs, namely, those of hantavirus, in which translation takes place via a cap-dependent mechanism, but the function of eIF4A is substituted by a viral protein named N [45]. What makes this protein even more interesting is the fact that it also plays the roles of eIF4G and eIF4E. The advantage of the N function is not only the substitution of the eIF4F function; it is also able to differentiate between a viral and cellular mRNA, favoring viral mRNA, and consequently, the formation of new viral particles (Fig. 3a) [45]. This case shows the great diversity and multiple functions of viral proteins.
The Cotesia plutellae bracovirus (CpBV), a DNA virus (family: Polydnaviridae, genus: Bracovirus), inhibits cellular mRNA translation in infected cells through viral proteins that target eIF4A. It has been found that a viral protein termed CpBV15β is synthesized during the late phase of infection. This protein has a region homologous to that of eIF4G. CpBV15β has the characteristic of binding to eIF4A and sequestering it, thus avoiding the formation of eIF4F (Fig. 3b) [46]. In this late phase of infection, the mRNAs that can be translated contain secondary structures in their 5′ UTR that would only be present in viral mRNAs, resulting in their selection over cellular mRNAs [47].
Cellular initiation factors, such as eIF4G and PABP, have been reported as targets for coded proteases by some viruses [48,49,50,51]. There is evidence that eIF4A is a target for these viral proteases, such is the case of protease 3C, coded by foot and mouth disease virus. This protease also cuts eIF4G, making it capable of generating a synergic effect due the cuts of both factors, which results in a decrease of cellular protein synthesis via a cap-dependent mechanism, whereas viral protein synthesis takes place via a cap-independent mechanism (Fig. 3c) [52].
Research addressing the role of the trans-dominant eIF4A mutant and that of hippuristanol, a specific eIF4A inhibitor that prevents eIF4A from binding to mRNA, has confirmed that mRNAs with IRES in some viruses are resistant to these conditions, which suggests the independence of eIF4A from these translation processes. Such is the case for hepatitis C virus, classic swine fever virus [53], porcine teschovirus type 1 [54], and cricket paralysis viruses [55].
Viruses that modulate their requirement of eIF4A according to the context in which they are found
There are interesting examples of the versatility of viral mRNA concerning its translation requirements. Messenger RNA can alternate among different translational mechanisms depending on its current context. Sindbis virus is one of these examples; in infected cells and in cells transfected with replicons of the virus, viral protein synthesis is independent of eIF4A. However, when genomic and subgenomic mRNAs were transfected to cells via a vector, their expression was completely dependent on eIF4A. The presence of any viral protein that could be supplanting eIF4A function during infection has been experimentally discarded [56]; the results of this study suggest that Sindbis virus mRNAs are capable of adapting to different conditions depending on the availability of translation initiation factors.
The genomic mRNA of human immunodeficiency virus type 1 (HIV) has two AUG start codons that allow the synthesis of two isoforms of the Gag protein: codon 1 generates the p55 isoform, and it is translated via a cap-dependent mechanism that uses eIF4A and can switch to the cap-independent mechanism when an IRES structure is present in the 5′ UTR and Codon 2, which generates the p40 isoform, is only translated via cap-independent mechanism through an IRES found in the Gag’s ORF [57, 58]. This alternating behavior between cap-dependent and cap-independent translations of codon 1 suggests that some viral mRNAs have to be translated according to intracellular conditions and the availability of initiation factors in order to secure viral protein synthesis.
The eIF4A inhibitors
There are some compounds that have the characteristic of inhibiting eIF4A: silvestrol [59], hippuristanol [60], elisabatin and allolaurintenol [61], rocaglamide [62], and pateamine A and some of its derivatives [30]. These compounds are emerging as a new antiviral therapeutic strategy whose mechanism of action is the inhibition of eIF4A. Consistent with this, silvestrol has shown antiviral activity in vitro against RNA viruses: Ebola virus, hepatitis E, coronavirus, rhinovirus, and poliovirus [59, 63,64,65]. Hippuristanol has been tested in preclinical studies for possible use in patients with HTLV-1 [31]. Therefore, the use of compounds that inhibit the activity of eIF4A holds great interest in virology as antiviral agents.
Conclusions
Despite the important role of eIF4A in intracellular events, available information on how this protein participates during viral infection is scarce. The eIF4A protein participates in cap-dependent translation as part of the eIF4F complex; paradoxically, it also participates in cap-independent translation via IRES during some viral infections [66]. The fact that eIF4A participates in the replicative cycles of some viruses makes it useful for controlling infections. To date, there are compounds known to have a specific effect on eIF4A. Experimental use of these compounds has shown interesting results in animal study models [31]. Related preclinical studies serve as a foundation for the use of hippuristanol as a therapeutic treatment that could be used against some viral infections in which eIF4A is of high importance to viral replication.
References
Montero H, Garcia-Roman R, Mora SI (2015) eIF4E as a control target for viruses. Viruses 7(2):739–750. https://doi.org/10.3390/v7020739
Smith RW, Gray NK (2010) Poly(A)-binding protein (PABP): a common viral target. Biochem J 426(1):1–12. https://doi.org/10.1042/BJ20091571
Walsh D (2010) Manipulation of the host translation initiation complex eIF4F by DNA viruses. Biochem Soc Trans 38(6):1511–1516. https://doi.org/10.1042/BST0381511
Gale M Jr, Tan SL, Katze MG (2000) Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev 64(2):239–280. https://doi.org/10.1128/MMBR.64.2.239-280.2000
Jan E, Mohr I, Walsh D (2016) A cap-to-tail guide to mRNA translation strategies in virus-infected cells. Annu Rev Virol 3(1):283–307. https://doi.org/10.1146/annurev-virology-100114-055014
Bushell M, Sarnow P (2002) Hijacking the translation apparatus by RNA viruses. J Cell Biol 158(3):395–399. https://doi.org/10.1083/jcb.200205044
Gray NK, Wickens M (1998) Control of translation initiation in animals. Annu Rev Cell Dev Biol 14:399–458
Kapp LD, Lorsch JR (2004) The molecular mechanics of eukaryotic translation. Annu Rev Biochem 73:657–704
Wilkie GS, Dickson KS, Gray NK (2003) Regulation of mRNA translation by 5′- and 3′-UTR-binding factors. Trends Biochem Sci 28(4):182–188
Pickering BM, Willis AE (2005) The implications of structured 5′ untranslated regions on translation and disease. Semin cell Dev Biol 16(1):39–47
Pestova TV, Kolupaeva VG, Lomakin IB, Pilipenko EV, Shatsky IN, Agol VI, Hellen CU (2001) Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci USA 98(13):7029–7036
Preiss T, Hentze MW (2003) Starting the protein synthesis machine: eukaryotic translation initiation. Bioessays 25(12):1201–1211. https://doi.org/10.1002/bies.10362
Gingras AC, Raught B, Sonenberg N (1999) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913–963. https://doi.org/10.1146/annurev.biochem.68.1.913
Pestova TV, Hellen CU (2000) The structure and function of initiation factors in eukaryotic protein synthesis. Cell Mol Life Sci 57(4):651–674
Kimball SR (1999) Eukaryotic initiation factor eIF2. Int J Biochem Cell Biol 31(1):25–29
Proud CG (2005) eIF2 and the control of cell physiology. Semin Cell Dev Biol 16(1):3–12
Andreou AZ, Klostermeier D (2013) The DEAD-box helicase eIF4A: paradigm or the odd one out? RNA Biol 10(1):19–32. https://doi.org/10.4161/rna.21966
Lu WT, Wilczynska A, Smith E, Bushell M (2014) The diverse roles of the eIF4A family: you are the company you keep. Biochem Soc Trans 42(1):166–172. https://doi.org/10.1042/BST20130161
Garcia-Garcia C, Frieda KL, Feoktistova K, Fraser CS, Block SM (2015) RNA BIOCHEMISTRY. Factor-dependent processivity in human eIF4A DEAD-box helicase. Science 348(6242):1486–1488. https://doi.org/10.1126/science.aaa5089
Sonenberg N, Rupprecht KM, Hecht SM, Shatkin AJ (1979) Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP. Proc Natl Acad Sci USA 76(9):4345–4349
Rogers GW Jr, Komar AA, Merrick WC (2002) eIF4A: the godfather of the DEAD box helicases. Prog Nucleic Acid Res Mol Biol 72:307–331
Parsyan A, Svitkin Y, Shahbazian D, Gkogkas C, Lasko P, Merrick WC, Sonenberg N (2011) mRNA helicases: the tacticians of translational control. Nat Rev Mol Cell Biol 12(4):235–245. https://doi.org/10.1038/nrm3083
Jackson RJ, Hellen CU, Pestova TV (2010) The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 11(2):113–127. https://doi.org/10.1038/nrm2838
Tuteja N, Vashisht AA, Tuteja R (2008) Translation initiation factor 4A: a prototype member of dead-box protein family. Physiol Mol Biol Plants 14(1–2):101–107. https://doi.org/10.1007/s12298-008-0009-z9
Galicia-Vazquez G, Cencic R, Robert F, Agenor AQ, Pelletier J (2012) A cellular response linking eIF4AI activity to eIF4AII transcription. RNA 18(7):1373–1384. https://doi.org/10.1261/rna.033209.112
Mazroui R, Sukarieh R, Bordeleau ME, Kaufman RJ, Northcote P, Tanaka J, Gallouzi I, Pelletier J (2006) Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2alpha phosphorylation. Mol Biol Cell 17(10):4212–4219
Montero H, Trujillo-Alonso V (2011) Stress granules in the viral replication cycle. Viruses 3(11):2328–2338. https://doi.org/10.3390/v3112328
Kedersha NL, Gupta M, Li W, Miller I, Anderson P (1999) RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol 147(7):1431–1442
Bordeleau ME, Cencic R, Lindqvist L, Oberer M, Northcote P, Wagner G, Pelletier J (2006) RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation. Chem Biol 13(12):1287–1295. https://doi.org/10.1016/j.chembiol.2006.10.005
Low WK, Li J, Zhu M, Kommaraju SS, Shah-Mittal J, Hull K, Liu JO, Romo D (2014) Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents. Bioorg Med Chem 22(1):116–125. https://doi.org/10.1016/j.bmc.2013.11.046
Tsumuraya T, Ishikawa C, Machijima Y, Nakachi S, Senba M, Tanaka J, Mori N (2011) Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia. Biochem Pharmacol 81(6):713–722. https://doi.org/10.1016/j.bcp.2010.12.025
Pelletier J, Sonenberg N (1988) Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334(6180):320–325
Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E (1988) A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62(8):2636–2643
Jan E, Sarnow P (2002) Factorless ribosome assembly on the internal ribosome entry site of cricket paralysis virus. J Mol Biol 324(5):889–902
Belsham GJ, Sonenberg N (1996) RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol Rev 60(3):499–511
Lewis SM, Holcik M (2008) For IRES trans-acting factors, it is all about location. Oncogene 27(8):1033–1035
Andino R, Boddeker N, Silvera D, Gamarnik AV (1999) Intracellular determinants of picornavirus replication. Trends Microbiol 7(2):76–82
Kwan T, Thompson SR (2018) Noncanonical translation initiation in eukaryotes. Cold Spring Harbor Perspect Biol. https://doi.org/10.1101/cshperspect.a032672
Aoyagi M, Gaspar M, Shenk TE (2010) Human cytomegalovirus UL69 protein facilitates translation by associating with the mRNA cap-binding complex and excluding 4EBP1. Proc Natl Acad Sci USA 107(6):2640–2645. https://doi.org/10.1073/pnas.0914856107
Perez C, McKinney C, Chulunbaatar U, Mohr I (2011) Translational control of the abundance of cytoplasmic poly(A) binding protein in human cytomegalovirus-infected cells. J Virol 85(1):156–164. https://doi.org/10.1128/JVI.01778-10JVI
Yanguez E, Castello A, Welnowska E, Carrasco L, Goodfellow I, Nieto A (2011) Functional impairment of eIF4A and eIF4G factors correlates with inhibition of influenza virus mRNA translation. Virology 413(1):93–102. https://doi.org/10.1016/j.virol.2011.02.012
Kolupaeva VG, Lomakin IB, Pestova TV, Hellen CU (2003) Eukaryotic initiation factors 4G and 4A mediate conformational changes downstream of the initiation codon of the encephalomyocarditis virus internal ribosomal entry site. Mol Cell Biol 23(2):687–698
Othman Z, Sulaiman MK, Willcocks MM, Ulryck N, Blackbourn DJ, Sargueil B, Roberts LO, Locker N (2014) Functional analysis of Kaposi’s sarcoma-associated herpesvirus vFLIP expression reveals a new mode of IRES-mediated translation. RNA 20(11):1803–1814. https://doi.org/10.1261/rna.045328.114
Chaudhry Y, Nayak A, Bordeleau ME, Tanaka J, Pelletier J, Belsham GJ, Roberts LO, Goodfellow IG (2006) Caliciviruses differ in their functional requirements for eIF4F components. J Biol Chem 281(35):25315–25325. https://doi.org/10.1074/jbc.M602230200
Mir MA, Panganiban AT (2008) A protein that replaces the entire cellular eIF4F complex. EMBO J 27(23):3129–3139
Lee S, Kim Y (2008) Two homologous parasitism-specific proteins encoded in Cotesia plutellae bracovirus and their expression profiles in parasitized Plutella xylostella. Arch Insect Biochem Physiol 67(4):157–171. https://doi.org/10.1002/arch.20218
Surakasi VP, Nalini M, Kim Y (2011) Host translational control of a polydnavirus, Cotesia plutellae bracovirus, by sequestering host eIF4A to prevent formation of a translation initiation complex. Insect Mol Biol 20(5):609–618. https://doi.org/10.1111/j.1365-2583.2011.01091.x
Joachims M, Van Breugel PC, Lloyd RE (1999) Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol 73(1):718–727
Alvarez E, Castello A, Menendez-Arias L, Carrasco L (2006) HIV protease cleaves poly(A)-binding protein. Biochem J 396(2):219–226. https://doi.org/10.1042/BJ20060108
Hsu YY, Liu YN, Lu WW, Kung SH (2009) Visualizing and quantifying the differential cleavages of the eukaryotic translation initiation factors eIF4GI and eIF4GII in the enterovirus-infected cell. Biotechnol Bioeng 104(6):1142–1152. https://doi.org/10.1002/bit.22495
Gradi A, Svitkin YV, Imataka H, Sonenberg N (1998) Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc Natl Acad Sci USA 95(19):11089–11094
Belsham GJ, McInerney GM, Ross-Smith N (2000) Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J Virol 74(1):272–280
Pestova TV, Shatsky IN, Fletcher SP, Jackson RJ, Hellen CU (1998) A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev 12(1):67–83
Pisarev AV, Chard LS, Kaku Y, Johns HL, Shatsky IN, Belsham GJ (2004) Functional and structural similarities between the internal ribosome entry sites of hepatitis C virus and porcine teschovirus, a picornavirus. J Virol 78(9):4487–4497
Bordeleau ME, Mori A, Oberer M, Lindqvist L, Chard LS, Higa T, Belsham GJ, Wagner G, Tanaka J, Pelletier J (2006) Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat Chem Biol 2(4):213–220
Garcia-Moreno M, Sanz MA, Pelletier J, Carrasco L (2013) Requirements for eIF4A and eIF2 during translation of Sindbis virus subgenomic mRNA in vertebrate and invertebrate host cells. Cell Microbiol 15(5):823–840. https://doi.org/10.1111/cmi.12079
de Breyne S, Chamond N, Decimo D, Trabaud MA, Andre P, Sargueil B, Ohlmann T (2012) In vitro studies reveal that different modes of initiation on HIV-1 mRNA have different levels of requirement for eukaryotic initiation factor 4F. FEBS J 279(17):3098–3111. https://doi.org/10.1111/j.1742-4658.2012.08689.x
Monette A, Valiente-Echeverria F, Rivero M, Cohen EA, Lopez-Lastra M, Mouland AJ (2013) Dual mechanisms of translation initiation of the full-length HIV-1 mRNA contribute to gag synthesis. PLoS ONE 8(7):e68108. https://doi.org/10.1371/journal.pone.0068108
Biedenkopf N, Lange-Grunweller K, Schulte FW, Weisser A, Muller C, Becker D, Becker S, Hartmann RK, Grunweller A (2017) The natural compound silvestrol is a potent inhibitor of Ebola virus replication. Antivir Res 137:76–81. https://doi.org/10.1016/j.antiviral.2016.11.011
Cencic R, Pelletier J (2016) Hippuristanol—a potent steroid inhibitor of eukaryotic initiation factor 4A. Translation (Austin) 4(1):e1137381. https://doi.org/10.1080/21690731.2015.1137381
Tillotson J, Kedzior M, Guimaraes L, Ross AB, Peters TL, Ambrose AJ, Schmidlin CJ, Zhang DD, Costa-Lotufo LV, Rodriguez AD, Schatz JH, Chapman E. Bioorganic (2017) ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A. Bioorg Med Chem Lett 27(17):4082–4085. https://doi.org/10.1016/j.bmcl.2017.07.045
Sadlish H, Galicia-Vazquez G, Paris CG, Aust T, Bhullar B, Chang L, Helliwell SB, Hoepfner D, Knapp B, Riedl R, Roggo S, Schuierer S, Studer C, Porco JA Jr, Pelletier J, Movva NR (2013) Evidence for a functionally relevant rocaglamide binding site on the eIF4A-RNA complex. ACS Chem Biol 8(7):1519–1527. https://doi.org/10.1021/cb400158t
Muller C, Schulte FW, Lange-Grunweller K, Obermann W, Madhugiri R, Pleschka S, Ziebuhr J, Hartmann RK, Grunweller A (2018) Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses. Antivir Res 150:123–129. https://doi.org/10.1016/j.antiviral.2017.12.010
Todt D, Moeller N, Praditya D, Kinast V, Friesland M, Engelmann M, Verhoye L, Sayed IM, Behrendt P, Dao Thi VL, Meuleman P, Steinmann E (2018) The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo. Antivir Res 157:151–158. https://doi.org/10.1016/j.antiviral.2018.07.010
Elgner F, Sabino C, Basic M, Ploen D, Grunweller A, Hildt E (2018) Inhibition of Zika virus replication by silvestrol. Viruses. https://doi.org/10.3390/v10040149
de Breyne S, Yu Y, Pestova TV, Hellen CU (2008) Factor requirements for translation initiation on the Simian picornavirus internal ribosomal entry site. RNA 14(2):367–380
Acknowledgements
This study was financially supported by Grant 222194 from the National Council for Science and Technology (Mexico).
Author information
Authors and Affiliations
Contributions
All authors contributed to writing the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Edited by Joachim Jakob Bugert.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Montero, H., Pérez-Gil, G. & Sampieri, C.L. Eukaryotic initiation factor 4A (eIF4A) during viral infections. Virus Genes 55, 267–273 (2019). https://doi.org/10.1007/s11262-019-01641-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11262-019-01641-7